Abstract
Current coronavirus vaccines are classical vaccines, i. e., are based on live attenuated coronavirus. These vaccines provide protection against certain strains of infectious bronchitis virus (IBV) and mouse hepatitis virus (MHV), and with variable results against bovine coronavirus (BCV) and transmissible gastroenteritis virus (TGEV).
Chapter PDF
References
Antón, I. M, González, S., Bullido, M. J., Suñé, C., Meloen, R. H., Borrás-Cuesta, F., Enjuanes, L. Immunodominant T cell epitopes of transmissible gastroenteritis virus major structural proteins. J. Virol. 1994. In press.
Armstrong, J., Niemann, H., Smeekens, S., Rottier, P., Warren, G. Sequence and topology of a model intracellular membrane protein. Nature 1984; 308: 751–752.
Baker, S. C, Lai, M. M. C. An In vitro system for the leader-primed transcription of coronavirus messenger RNAs. EMBO J. 1990; 9: 4173–4179.
Ball, A. L. cis-acting requirements for the replication of flock house virus RNA2. J. Virol. 1993; 67: 3544–3551.
Bett, A. J., Prevec, L., Graham, F. L. Packaging capacity and stability of human Adenovirus type 5 vectors. J.Virol. 1993;67:5911–5921.
Boots, A. M., Van-Lierop, M. J., Kusters, J. G., Van-Kooten, G. J., Van-der-Zeijst, B. A., Hensen, E. J. MHC ClassII-restricted T-cell hybridomas recognizing the nucleocapsid protein of avian coronavirus IBV. Immunology 1991; 72: 10–14.
Boots, A. M. H., Benaissatrouw, B. J., Hesselink, W., Rijke, E., Schrier, C., Hensen, E. J. Induction of anti-viral immune responses by immunization with recombinant-DNA encoded avian coronavirus nucleocapsid protein. Vaccine 1992; 10: 119–124.
Boots, A. M. H., Kusters, J. G., Vannoort, J. M., Zwaagstra, K. A., Rijke, E., Vanderzeijst, B. A. M., Hensen, E. J. Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus. Immunology 1991; 74: 8–13.
Boursnell, M. E., Brown, T. D. K., Binns, M. M. Sequence of the membrane protein gene from avian coronavirus IBV. Virus Res. 1984 1: 303–313.
Bousquet, F., Martin, C, Girardeau, J. P., Mechin, M. C., Vartanian, M. d. CS31A capsule-like antigen as an exposure vector for heterologous antigenic determinants. Infec. Immun. 1994; 62: 2553–2561.
Bredenbeeck, P. J., Rice, C. M. Animal RNA virus expression systems. Sem. Virol. 1992 3: 297–310.
Brown, C. S., Welling-Wester, S., Feijlbrief, M., Van Lent, J. W. M., Spaan, W. J. M. Chimeric Parvovirus B19 capsids for the presentation of foreign epitopes. Virology 1994; 198: 477–488.
Buchmeier, M. J., Lewicki, H. A., Talbot, P. J., Knobler, R. L. Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology 1984; 132: 261–270.
Castilla, J., Sola, I., Pintado, B., Hennighausen, L., Enjuanes, L. Expression of immunoglobulin genes in the mammary gland. Resistance to virus infection. 1994. Fundación Juan March, Madrid, Spain.
Cavanagh, D., Davis, P. J., Derbyshire, J. H., Peters, R. W. Coronavirus IBV: virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or haemagglutination-inhibiting antibody, or induce chicken tracheal protection. J. Gen. Virol. 1986; 67: 1435–1442.
Cavanagh, D., Davis, P. J., Mockett, A. P. Amino acids within hypervariable region 1 of avian coronavirus IBV (Massachusetts serotype) spike glycoprotein are associated with neutralizing epitopes. Virus Res. 1988; 11: 141–150.
Cavanagh, D., Derbyshire, J. H., Davis, P. J., Peters, R. W. Induction of humoral neutralising and haemagglutination-inhibiting antibody by the spike protein of avian infectious bronchitis virus. Avian Pathol. 1984; 13: 573–583.
Correa, I., Gebauer, F., Bullido, M. J., Suñé, C, Baay, M. F. D., Zwaagstra, K. A., Posthumus, W. P. A., Lenstra, J. A., Enjuanes, L. Localization of antigenic sites of the E2 glycoprotein of transmissible gastroenteritis coronavirus. J. Gen. Virol. 1990; 71: 271–279.
Correa, I., Jiménez, G., Suñé, C, Bullido, M. J., Enjuanes, L. Antigenic structure of the E2 glycoprotein from transmissible gastroenteritis coronavirus. Virus. Res. 1988; 10: 77–94.
Daniel, C, Anderson, R., Buchmeier, M. J., Fleming, J. O., Spaan, W. J. M., Wege, H., Talbot, P. J. Identification of an immunodominant linear neutralization domain on the S2 portion of the murine coronavirus spike glycoprotein and evidence that it forms part of a complex tridimensional structure. J. Virol. 1993; 67: 1185–1194.
De Groot, R. J., Andeweg, A. C., Horzinek, M. C., Spaan, W. J. M. Sequence analysis of the 3’ end of the feline coronavirus FIPV 79–1146 genome: comparison with the genome of porcine coronavirus TGEV reveals large insertions. J. Virol. 1988; 167: 370–376.
De Groot, R. J., Vandermost, R. G., Spaan, W. J. M. The fitness of defective interfering murine coronavirus-DI-a and its derivatives is decreased by nonsense and frameshift mutations. J. Virol. 1992; 66: 5898–5905.
Delmas, B., Gelfi, J., Laude, H. Antigenic structure of transmissible gastroenteritis virus. II. Domains in the peplomer glycoprotein. J. Gen. Virol. 1986; 67: 1405–1418.
Delmas, B., Rasschaert, D., Godet, M., Gelfi, J., Laude, H. Four major antigenic sites of the coronavirus transmissible gastroenteritis virus are located on the amino-terminal half of spike protein. J. Gen. Virol. 1990; 71: 1313–1323.
Deregt, D., Babiuck, L. A. Monoclonal antibodies to bovine coronavirus: characteristics and topographical mapping of neutralizing epitopes on the E2 and E3 glycoproteins. Virology 1987; 68: 41–420.
Enjuanes, L., Van der Zeijst, B. A. M. Molecular basis of transmissible gastroenteritis coronavirus (TGEV) epidemiology. In: Siddell S. G., (eds), Coronaviruses. Plenum Press, New York 1995. In press.
Fleming, J. O., Shubin, R. A., Sussman, M. A., Casteel, N., Stohlman, S. A. Monoclonal antibodies to the matrix (El) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology 1989; 168: 162–167.
Flory, E., Pfleiderer, M., Stuhler, A., Wege, H. Induction of protective immunity against coronavirus-induced encephalomyelitis: evidence for an important role of CD8+ T cells in vivo. Eur. J. Immunol 1993; 23: 1757–1761.
Garwes, D. J., Lucas, M. H., Higgins, D. A., Pike, B. V, Cartwright, S. F. Antigenicity of structural components from porcine transmissible gastroenteritis virus. Vet. Microbiol. 1978; 3: 179–190.
Gebauer, F., Posthumus, W. A. P., Correa, I., Suñé, C, Sánchez, C. M., Smerdou, C., Lenstra, J. A., Meloen, R., Enjuanes, L. Residues involved in the formation of the antigenic sites of the S protein of transmissible gastroenteritis coronavirus. Virology 1991; 183: 225–238.
Godet, M., L’Haridon, R., Vautherot, J. F., Laude, H. TGEV coronavirus ORF4 encodes a membrane protein that is incorporated into virions. Virology 1992; 188: 666–675.
Godet, M., Rasschaert, D., Laude, H. Processing and antigenicity of entire and anchor-free spike glycoprotein-S of coronavirus TGEV expressed by recombinant baculovirus. Virology 1991; 185: 732–740.
Hasony, H. J., MacNaughton, M. R. Antigenicity of mouse hepatitis virus strain 3 subcomponents in C57 strain mice. Arch. Virol. 1981; 69: 33–41.
Heemskerk, M. H. M., Schoemaker, H. M., Spaan, W. J. M., Boog, C. J. P. Induction of MHC class II-restricted CD4+ cytotoxic T cells by MHV-A59. European Immunology Meeting. 1994. Barcelona, Spain. W29.
Holmes, K. V, Doller, E. W., Behnke, J. N. Analysis of the functions of coronavirus glycoproteins by differential inhibition of synthesis with tunicamycin. Adv. Exp. Med. Biol. 1981; 142: 133.
Ignatovic, J., McWaters, P. G. Monoclonal antibodies to three structural proteins of avian infectious bronchitis virus : characterization of epitopes and antigenic differentiation of Australian strains. J. Gen. Virol. 199172:2915–2922.
Joo, M., Makino, S. Mutagenic analysis of the coronavirus intergenic consensus sequence. J. Virol. 1992; 66: 6330–6337.
Kapke, P. A., Tung, F. Y. T., Hogue, B. G., Brian, D. A., Woods, R. D., Wesley, R. The amino-terminal signal peptide on the porcine transmissible gastroenteritis coronavirus matrix protein is not an absolute requirement for membrane translocation and glycosylation. Virology 1988; 165: 367–376.
Kim, Y. N., Lai, M. M. C., Makino, S. Generation and selection of coronavirus defective interfering RNA with large open reading frame by RNA recombination and possible editing. Virology 1993; 194: 244–253.
Koetzner, C. A., Parker, M. M., Ricard, C. S., Sturman, L. S., Masters, P. S. Repair and mutagenesis of the genome of a deletion mutant of the coronavirus mouse hepatitis virus by targeted RNA recombination. J.Virol. 1992; 66: 1841–1848.
Kolb, A., Grosse, B., Siddell, S. G. Immunological prevention of coronavirus infection. Resistance to viral infection. 1994. Fundación Juan March, Madrid, Spain.
Konings, D. A. M., Bredenbeek, P. J., Noten, J. F. H., Hogeweg, P., Spaan, W. J. M. Differential premature termination of transcription as a proposed mechanism for the regulation of coronavirus gene expression. Nuc. Ac. Res. 1988; 16: 10849–10860.
Koolen, M. J. M., Borst, M. A. J., Horzinek, M. C., Spaan, W. J. M. Immunogenic peptide comprising a mouse hepatitis virus A59 B-cell epitope and an influenza virus T-cell epitope protects against lethal infection. J. Virol. 1990; 64: 6270–6273.
Kubo, H., Taguchi, F. Expression of the S1 and S2 subunits of murine coronavirus JHMV spike protein by vaccinia virus transient expression system. J. Gen. Virol. 1993; 74: 2372–2383.
Kyuwa, S., Stohlman, S. Advances in the study of MHV infection of mice. Adv. Exp. Med. Biol. 1990; 276: 555–556.
Lai, M. M. C. Coronavirus -organization, replication and expression of genome. Ann. Rev. Microbiol. 1990; 44: 303–333.
Lapps, W., Hogue, B. G., Brian, D. A. Sequence analysis of the bovine coronavirus nucleocapsid and matrix protein genes. Virology 1987; 157: 47–57.
Laude, H., Chapsal, J. M., Gelfi, J., Labiau, S., Grosclaude, J. Antigenic structure of transmissible gastroenteritis virus. I Properties of monoclonal antibodies directed against virion proteins. J. Gen. Virol. 1986; 67: 119–130.
Laude, H., Gelfi, J., Lavenant, L., Charley, B. Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus. J. Virol. 1992; 66: 743–749.
Laude, H., Rasschaert, D., Huet, J. C. Sequence and N-terminal processing of the transmembrane protein El of the coronavirus transmissible gastroenteritis virus. J. Gen. Virol. 1987; 68: 1687–1693.
Laviada, M. D., Videgain, S. R, Moreno, L., Alonso, F., Enjuanes, L., Escribano, J. M. Expression of swine transmissible gastroenteritis virus envelope antigens on the surface of infected cells: epitopes externally exposed. Vir. Res. 1990; 16: 247–254.
Lecomte, J., Cainelli-Cebera, V, Mercier, G., Mansour, S., Talbot, R, Lussier, G., Oth, D. Protection from mouse hepatitis virus type 3-induced acute disease by an anti-nucleoprotein monoclonal antibody. Arch. Virol. 1987; 97: 123–130.
Lenstra, J. A., Erkens, J. H. R, Langeveld, J. G. A., Posthumus, W. P. A., Meloen, R. H., Gebauer, F., Correa, I., Enjuanes, L., Stanley, K. K. Isolation of sequences from a random-sequence expression library that mimic viral epitopes. J. Immunol. Meth. 1992; 152: 149–157.
Lenstra, J. A., Kusters, J. G., Koch, G., van der Zeijst, B. A. M. Antigenicity of the peplomer protein of infectious bronchitis virus. Molec. Immunol. 1989; 26: 7–15.
Liao, C.-L., Lai, M. M. C. The requirement of 5’-end genomic sequence as an upstream cis-acting element for coronavirus subgenomic mRNA transcription. J. Virol. 1994; In Press.
Liljeström, P., Garoff, H. A new generation of animal cell expression vectors based on the Semliki forest virus replicon. Biotechnology 1991; 9: 1356–1361.
Lin, Y. J., Lai, M. M. C. Deletion mapping of a mouse hepatitis virus defective interfering RNA reveals the requirement of an internal and discontiguous sequence for replication. J. Virol. 1993; 67: 6110–6118.
Luytjes, W., Geerts, D., Posthumus, W., Meloen, R., Spaan, W. J. M. Amino acid sequence of a conserved neutralizing epitope of murine coronaviruses. J. Virol. 1989; 63: 1408–1415.
Makino, S., Fleming, J. O., Keck, J. G., Stohlman, S. T., Lai, M. M. C. RNA recombination of coronaviruses: localization of neutralizing epitopes and neuropathogenic determinants on the carboxyl terminus of peplomers. Proc. Natl. Acad. Sci. 1987; 84: 6567–6571.
Makino, S., Joo, M., Makino, J. K. A System for study of coronavirus messenger RNA synthesis -a regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion. J. Virol. 1991;65:6031–6041.
Makino, S., Yokomori, K., Lai, M. M. C. Analysis of efficiently packaged defective interfering RNAs of murine coronavirus -localization of a possible RNA-packaging signal. J. Virol. 1990; 64: 6045–6053.
Mengeling, W. L. Porcine coronaviruses: co-infection of cell cultures with transmissible gastroenteritis virus and hemagglutinating encephalomyelitis. Am. J. Vet. Res. 1973; 34: 779–783.
Mizutani, T., Hayashi, M., Maeda, A., Sasaki, N., Yamashsita, T., Kasai, N., Namioka, S. Inhibition of mouse hepatitis virus multiplication by antisense oligonucleotide, antisense RNA, sense RNA, and ribozyme. Adv. Exp. Med. Biol. 1994; 276: 129–135.
Nakanaga, K., Yamanouchi, K., Fujiwara, K. Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice. J. Virol. 1986; 59: 168–171.
Niesters, H. G. M., Lenstra, J. A., Spaan, W. J. M., Zijderveld, A. J., Bleumink-Pluym, N. M. C, van der Zeijst, B. A. M. The peplomer protein sequence of the M41 strain of coronavirus IBV and its comparison with Beaudette strains. Vir. Res. 1986; 5: 253–263.
Olsen, C. W. A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination. Vet. Microbiol. 1993; 36: 1–37.
Parker, M. M., Masters, P. S. Sequence comparison of the N genes of five strains of the coronavirus mouse hepatitis virus suggests a three domain structure for the nucleocapsid protein. Virology 1990; 179: 463–468.
Posthumus, W. P. A., Lenstra, J. A., van Nieuwstadt, A. P., Schaaper, W. M. M., van der Zeijst, B. A. M., Meloen, R. H. Immunogenicity of peptides simulating a neutralizing epitope of transmissible gastroenteritis virus. Virology 1991; 182: 371–375.
Posthumus, W. P. A., Meloen, R. H., Enjuanes, L., Correa, I., van Nieuwestadt, A., Koch, G. Linear neutralizing epitopes on the peplomer protein of coronaviruses. Adv. Exp. Med. Biol. 1990; 276: 181–188.
Pulford, D. J., Britton, P. Expression and cellular localisation of porcine transmissible gastroenteritis virus N and M proteins by recombinant vaccinia viruses. Vir. Res. 1990; 18: 203–218.
Reddy, P. S., Nagy, E., Derbishire, J. B. Restriction endonuclease analysis and molecular cloning of porcine adenovirus type 3. Intervirology 1993; 36: 161–168.
Risco, C., Antón, I. M., Suñé, C., Pedregosa, A. M., Martín-Alonso, J. M., Parra, F., Carrascosa, J. L., Enjuanes, L. The membrane protein of transmissible gastroenteritis coronavirus exposes the carboxy-terminal region on the external surface of the virion. 1994. Submitted.
Routledge, E., Stauber, R., Pfleiderer, M., Siddell, S. G. Analysis of murine coronavirus surface glycoprotein functions by using monoclonal antibodies. J. Virol. 1991; 65: 254–262.
Saif, L. J., Wesley, R. D. Transmissible gastroenteritis. In: Leman A. D., Straw, B., Mengeling, W. L., D’ Allaire, S., Taylor, D. J., (eds), Diseases of swine. Iowa State University Press, Ames, Iowa 1992, pp. 362–386
Sánchez, C. M., Jiménez, G., Laviada, M. D., Correa, I., Suñé, C., Bullido, M. J., Gebauer, F., Smerdou, C., Callebaut, P., Escribano, J. M., Enjuanes, L. Antigenic homology among coronaviruses related to transmissible gastroenteritis virus. Virology 1990; 174: 410–417.
Sánchez, C. M., Torres, J. M., Suñé, C., Smerdou, C., Graham, F. L., Enjuanes, L. Transmissible gastroenteritis coronavirus spike protein expressed by adenovirus vectors elicited virus neutralizing antibodies in hamsters. 1994. Submitted.
Sasaki, N., Hayashi, M., Aoyama, S., Yamashita, T., Miyoshi, I., Kasai, N., Namioka, S. Transgenic mice with antisense RNA against the nucleocapsid protein mRNA of mouse hepatitis virus. J. Vet. Med. Sci. 1993; 55:549–554.
Scott, F. W., Corapi, W. V., Olsen, C. W. Evaluation of the safety and efficacy of Primucell-FIPR vaccine. Feline Health Topics 1992; 7: 6–8.
Sethna, P. B., Hung, S.-L., Brian, D. A. Coronavirus subgenomic minus-strand RNAs and the potential for mRNA replicons. Proc. Natl. Acad. Sci. USA 1989; 86: 5626–5630.
Smerdou, C., Antón, I. M., Plana, J., Curtiss, R., Enjuanes, L. Expression of a continuos epitope from Transmissible gastroenteritis coronavirus S protein fused to E. coli heat-labile toxin B subunit in attenuated Salmonella for oral immunization. 1994. Submitted.
Smith-Kline, B. Universal coronavirus vaccine; spike protein cloning and expression for use as a recombinant vaccine. Vaccine 1994; 12: 671.
Spaan, W., Cavanagh, D., Horzinek, M. C. Coronaviruses: structure and genome expression. J. Gen. Virol. 1988;69:2939–2952.
Spaan, W., Cavanagh, D., Horzinek, M. C. Coronaviruses. In: van Regenmortel M. H. V., Neurath, A. R., (eds.), Immunochemistry of viruses II. The basis for serodiagnosis and vaccines. Elsevier, 1990, pp. 359–379
Stohlman, S. A., Bergmann, C., Cua, D., Wege, H. Location of antibody epitopes within the mouse hepatitis virus nucleocapsid protein. Virology 1994; 202: 146–153.
Stohlman, S. A., Kyuwa, S., Cohen, M., Bergmann, C, Polo, J. M., Yeh, J., Anthony, R., Keck, J. G. Mouse hepatitis virus nucleocapsid protein-specific cytotoxic T lymphocytes are Ld restricted and specific for the carboxy terminus. Virology 1992; 189: 217–224.
Sturman, L., Holmes, K., V. The novel proteins of coronaviruses. Trends Biochem. Sci. 1985; 10: 17–20.
Talbot, P. J., Dionne, G., Lacroix, M. Vaccination against lethal coronavirus-induced encephalitis with a synthetic decapeptide homologous to a domain in the predicted peplomer stalk. J. Virol. 1988; 62: 3032–3036.
Talbot, P. J., Salmi, A. A., Knobler, R. L., Buchmeier, M. J. Topographical mapping of epitopes on the glycoprotein of murine hepatitis virus-4 (Strain JHM): correlation with biological activities. Virology 1984; 132:250–260.
To, L. T., Bernard, S., Lantier, I. Fixed-cell immunoperoxidase technique for the study of surface antigens induced by the coronavirus of transmissible gastroenteritis (TGEV). Vet. Microbiol. 1991; 29: 361–368.
Tooze, S. A., Stanley, K. K. Identification of two epitopes in the carboxyterminal 15 amino acids of the E1 glycoprotein of mouse hepatitis virus A59 by using hybrid proteins. J. Virol. 1986; 60: 928–934.
Torres, J. M., Escribano, J. A. M., Enjuanes, L. Induction of lactogenic immunity to transmissible gastroenteritis coronavirus with recombinant Adenovirus 5 expressing TGEV spike protein. 1995. Submitted.
Tung, F. Y. T., Abraham, S., Sethna, M., Hung, S. L., Sethna, P., Hogue, B. G., Brian, D. A. The 9-kDa hydrophobic protein encoded at the 3’ end of the porcine transmissible gastroenteritis coronavirus genome is membrane-associated. Virology 1992; 186: 676–683.
van der Most, R. G., Bredenbeek, P. J. A domain at the 3’ end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs. J. Virol. 1991; 65: 3219–3226.
van der Most, R. G., Bredenbeek, P. J., Spaan, W. J. M. A domain at the 3’ end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs. J. Virol. 1991; 65: 3219–3226.
van der Most, R. G., De Groot, R. J., Spaan, W. J. M. Subgenomic RNA synthesis directed by a synthetic defective interfering RNA of mouse Hepatitis virus: a study of Coronavirus transcription initiation. J. Virol. 1994; 68: 3656–3666.
van der Most, R. G., Heijnen, L., Spaan, W. J. M., Degroot, R. J. Homologous RNA recombination allows efficient introduction of site-specific mutations into the genome of coronavirus MHV-A59 via synthetic coreplicating RNAs. Nuc. Ac. Res. 1992; 20: 3375–3381.
Vennema, H., De Groot, R. J., Harbour, D. A., Horzinek, M. C., Spaan, W. J. M. Primary structure of the membrane and nucleocapsid protein genes of Feline infectious peritonitis virus and immunogenicity of recombinant vaccinia viruses in kittens. Virology 1991; 181: 327–335.
Vennema, H., DeGroot, R. J., Harbour, D. A., Dalderup, M., Gruffydd-Jones, T., Horzinek, M. C., Spaan, W. J. M. Early death after feline infectious peritonitis challenge due to recombinant vaccinia virus immunization. J. Virol. 1990; 64: 1407–1409.
Wang, F. I., Fleming, J. O., Lai, M. M. C. Sequence analysis of the spike protein gene of murine coronavirus variants: Study of genetic sites affecting neuropathogenicity. Virology 1992; 186: 742–749.
Wege, H., Schliephake, A., Körner, H., Flory, E., Wege, H. Coronavirus induced encephalomyelitis: an immunodominant CD4+-T cell site on the nucleocapsid protein contributes to protection. Adv. Exp. Med. Biol. 1994;342:413–418.
Welch, S. K. W., Saif, L. J. Monoclonal antibodies to a virulent strain of transmissible gastroenteritis virus: comparison of reactivity with virulent and attenuated virus. Arch. Virol. 1988; 101: 221–235.
Wesseling, J. G., Godeke, G. J. Mouse hepatitis virus spike and nucleocapsid proteins expressed by adenovirus vector protect mice against a lethal infection. J. Gen. Virol. 1993; 74: 2061–2069.
Williamson, J. S. P., Stohlman, S. A. Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells. J. Virol. 1990; 64: 4589–4592.
Woods, R. D., Wesley, R. D., Kapke, P. A. Complement-dependent neutralization of transmissible gastroenteritis virus by monoclonal antibodies. Adv. Exp. Med. Biol. 1987; 218: 493–500.
Yoden, S., Kikuchi, T., Siddell, S. G., Taguchi, F. Expression of the peplomer glycoprotein of murine coronavirus JHM using a baculovirus vector. Virology 1989; 173: 615–623.
Yoo, D., Parker, M. D., Babiuk, L. A. The S2 subunit of the spike glycoprotein of bovine coronavirus mediates membrane fusion in insect cells. Virology 1991; 180: 395–399.
Yoo, D., Parker, M. D., Song, J., Graham, F. L., Deregt, D., Babiuk, L. A. Structural analysis of the conformational domains involved in neutralization of Bovine Coronavirus using deletion mutants of the spike glycoprotein S1 subunit expressed by recombinant baculoviruses. Virology 1991; 183: 91 – 98.
Yoo, D. W., Graham, F. L., Prevec, L., Parker, M. D., Benko, M., Zamb, T., Babiuk, L. A. Synthesis and processing of the haemagglutinin-esterase glycoprotein of bovine coronavirus encoded in the E3 region of adenovirus. J. Gen. Virol. 1992; 73: 2591–2600.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Enjuanes, L. et al. (1995). Development of Protection against Coronavirus Induced Diseases. In: Talbot, P.J., Levy, G.A. (eds) Corona- and Related Viruses. Advances in Experimental Medicine and Biology, vol 380. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1899-0_34
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1899-0_34
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5775-9
Online ISBN: 978-1-4615-1899-0
eBook Packages: Springer Book Archive